patient
-
New pulmonary embolism treatments offer patients freedom from needles
Treatments for pulmonary embolisms (PE) will evolve to better suit patient needs and enhance their quality of life, according to a report by GlobalData.
patient | 24 May 2012
-
New data presented on phase 3 trial Of ELIQUIS (apixaban) in the prevention of venous thromboembolism in patients with acute medical illness
Bristol-Myers Squibb and Pfizer announced the results of the Phase 3 ADOPT (Apixaban Dosing to Optimize Protection from Thrombosis) trial, which evaluated apixaban versus enoxaparin in acutely ill medical patients, did not meet the primary efficacy outcome of superiority to enoxaparin for the endpoint of venous thromboembolism (VTE) and VTE-related death at day 30.
patient | 15 November 2011
-
Dr Reddy's starts phase 2 study with CETP inhibitor in dyslipidemia patients
Dr Reddy's Laboratories announced the initiation of dosing with DRL-17822 in patients with diagnosis of type 2 dyslipidemia. DRL-17822 is a selective, orally bioavailable inhibitor of cholesteryl ester transfer protein (CETP), for the treatment and/or prevention of dyslipidemia, atherosclerosis and associated cardiovascular disease.
patient | 05 September 2011
-
Genzyme announces winners of Patient Advocacy Leadership awards
Genzyme, a Sanofi company, announced the first recipients of the Genzyme Patient Advocacy Leadership (PAL) Awards. This global grant program supports non-profit organizations that work on behalf of patients living with lysosomal storage disorders (LS…
patient | 17 August 2011
-
Pfizer announces phase 3 study results of patients with Fibromyalgia in Japan
Pfizer Japan announced the top-line results for Lyrica (pregabalin) Study A0081208 – Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate Efficacy and Safety of Pregabalin (CI-1008) in the Treatment of Fibromyalgia. According…
patient | 07 July 2011
-
Sanofi enters global agreement to improve quality of patient care
Sanofi announced that it has entered into a global agreement with Medco Health Solutions Inc and United BioSource Corporation (UBC) to better leverage the real-world evidence generated during product development and throughout the product lifecycle i…
patient | 22 June 2011
-
Pfizer, Hisun to deliver quality, low-cost medicines for patients in China
Pfizer Inc and Zhejiang Hisun Pharmaceuticals jointly announced the signing of a memorandum of understanding (MOU) on their intention to establish a joint venture. This potential partnership would aim to strengthen the ability of both companies to re…
patient | 06 June 2011
-
Rheumatoid arthritis patients value personalised goal setting
UCB announced data that showed patients with rheumatoid arthritis (RA) believe that personalised goal setting can have a positive impact on their disease management. However, while the majority of patients surveyed (87%) agreed with this, almost as m…
patient | 26 May 2011
-
Sanofi commits to research and treatments for cancer patients
Sanofi announced that data from eight compounds in the company’s robust oncology portfolio will be showcased in more than 100 abstracts at the 47th Annual Meeting of the American Society of Clinical Oncology (ASCO)in Chicago, June 3-7, 2011. Dat…
patient | 19 May 2011
-
Sucampo, Abbott present clinical trial data of lubiprostone in Japanese patients
Sucampo Pharmaceuticals, Inc and Abbott data from a phase 3 clinical efficacy trial in 124 Japanese chronic idiopathic constipation (CIC) patients as well as from a phase 3 long term safety trial in an additional 209 Japanese CIC patients. The purpos…
patient | 11 May 2011
